Delivra Health Brands Inc. (TSXV: DHB)
Health Care · Pharmaceuticals · CA
CA$0.13
+8.33% today · -40.0% 1Y
Delivra Health Brands Inc. (TSXV: DHB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.72M and employs 22 people.
Over the last twelve months the share price has lost 40.0%, trading between 0.09 and 0.37.
Tweenvest scores Delivra Health Brands Inc. across four factors: quality 56/100, value 82/100, growth 66/100. Its strongest factor is value.
DHB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.72M
- Revenue (TTM)
- $8.06M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- CA$0.37
- 52-week low
- CA$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 31.26M
- Employees
- 22
- Next earnings
- —
About Delivra Health Brands Inc.
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's product line includes cannabis, liquid sleep supplements, powdered sleep aids, edible gummies, and topical pain relief solutions. These items are available under well-known brand labels like LivRelief, Dream Water, and LivRelief Infused. The company was formerly recognized as Harvest One Cannabis Inc.
- ISIN
- CA24703H2019
- Listed since
- Mar 31, 2017
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,199.54 | -2.77% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.17 | -1.09% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.46 | -0.40% |
Figures last refreshed Aug 18, 2026.